System, method and computer simulation environment for in silico trials in pre-diabetes and type 2 diabetes

US11238990B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11238990-B2
Application numberUS-201013380839-A
CountryUS
Kind codeB2
Filing dateJun 25, 2010
Priority dateJun 26, 2009
Publication dateFeb 1, 2022
Grant dateFeb 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An electronic system is provided that simulates a glucose-insulin metabolic system of a T2DM or prediabetic subject, wherein the system includes a subsystem that models dynamic glucose concentration in a T2DM or prediabetic subject, including an electronic module that models endogenous glucose production (EGP(t)), or meal glucose rate of appearance (Ra(t>>, or glucose utilization (U(t)), or renal excretion of glucose (B(t)), a subsystem that models dynamic insulin concentration in said T2DM or prediabetic subject, including an electronic module that models insulin secretion (S(t)), an electronic database containing a population of virtual T2DM or prediabetic subjects, each virtual subject having a plurality of metabolic parameters, and a processing module that calculates an effect of variation of at least one metabolic parameter value on the glucose insulin metabolic system of a virtual subject by inputting the plurality of metabolic parameter values.

First claim

Opening claim text (preview).

What is claimed is: 1. An electronic system that simulates a glucose-insulin metabolic system of a T2DM or prediabetic subject, comprising: a subsystem that models dynamic glucose concentration in a T2DM or prediabetic subject, including: an electronic module that models endogenous glucose production (EGP(t)) of a T2DM or prediabetic subject, an electronic module that models meal glucose rate of appearance (Ra(t)) of a T2DM or prediabetic subject, an electronic module that models glucose utilization (U(t)) of a T2DM or prediabetic subject, an electronic module that models renal excretion of glucose (E(t)) of a T2DM or prediabetic subject; a subsystem that models dynamic insulin concentration in said T2DM or prediabetic subject, including: an electronic module that models insulin secretion (S(t)) of a T2DM or prediabetic subject; an electronic database containing a population of virtual T2DM or prediabetic subjects representative of the T2DM and prediabetic population, each virtual subject having a plurality of metabolic parameters with values encompassing a distribution of parameters observed in vivo across the population of T2DM or prediabetic subjects; and a processor that calculates an effect of variation of at least one metabolic parameter value on the glucose-insulin metabolic system of a virtual T2DM or prediabetic subject by inputting said plurality of metabolic parameter values of said T2DM or prediabetic subject into said glucose concentration and insulin concentration subsystems and varying at least one of said metabolic parameter values to determine its effect on the glucose-insulin metabolic system of said T2DM or prediabetic subject. 2. An electronic system as set forth in claim 1 , wherein said glucose concentration subsystem models T2DM or prediabetic glucose concentration G(t) in accordance with the following equations:   { G . p ⁡ ( t ) = EGP ⁡ ( t ) + Ra ⁡ ( t ) - U ii ⁡ ( t ) - E ⁡ ( t ) - G p ⁡ ( 0 ) = G pb k 1 · G p ⁡ ( t ) + k 2 · G t ⁡ ( t ) G . t ⁡ ( t ) = - U id ⁡ ( t ) + k 1 · G p ⁡

Assignees

Inventors

Classifications

  • for patient-specific data, e.g. for electronic patient records · CPC title

  • G16H50/50Primary

    for simulation or modelling of medical disorders · CPC title

  • Computing arrangements using knowledge-based models · CPC title

  • Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor · CPC title

  • Monitoring progression or stage of a disease · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11238990B2 cover?
An electronic system is provided that simulates a glucose-insulin metabolic system of a T2DM or prediabetic subject, wherein the system includes a subsystem that models dynamic glucose concentration in a T2DM or prediabetic subject, including an electronic module that models endogenous glucose production (EGP(t)), or meal glucose rate of appearance (Ra(t>>, or glucose utilization (U(t)), or ren…
Who is the assignee on this patent?
Kovatchev Boris P, Cobelli Claudio, Dalla Man Chiara, and 1 more
What technology area does this patent fall under?
Primary CPC classification G16H50/50. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).